Ra Medical Systems, Inc. completed its acquisition of Catheter Precision, Inc. through a merger agreement, with Catheter becoming a wholly-owned subsidiary of Ra Medical. Catheter has three product areas: VIVO, Amigo, and a vessel closure device. The merger agreement also includes a private placement with Armistice Master Fund Ltd. for approximately $8.0 million. The Series X Convertible Preferred Stock was issued in connection with the merger. Changes in management include the appointment of David Jenkins and James Caruso to the board of directors, with Jenkins becoming Executive Chairman. Richard Mejia, Jr. and Joan Stafslien resigned from the board. The company also entered into support agreements and lock-up agreements with certain stakeholders. The filing also includes information about the Warrant Repricing and the issuance of securities in the private placement.